Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV studies identify risk factors in older adults, household transmission routes​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study shows nirsevimab provides significant protection against RSV​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Reports describe good maternal RSV vaccine, drug uptake in their first season​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV vaccine prompts robust immune response in older recipients over 2 seasons​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity climbs, with more deaths in kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
VA study shows COVID more severe than RSV, flu​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu markers show more rises as COVID levels decline​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Real-world study: RSV vaccine 78% to 80% effective against infection, severe illness in older US veterans​

One Health,
One Society:
Bridging Disciplines
for a Healthier World

MENU

NEWSLETTER

Subscribe to our newsletter and stay up to date with all events coming straight in your mailbox:

FOLLOW US

Facebook X-twitter Instagram Linkedin
Copyright © 2025 BioUnison LLC, All Rights Reserved.
One Health Society: A BioUnison Initiative
Privacy Policy | Terms of use